361 related articles for article (PubMed ID: 37040532)
1. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
[TBL] [Abstract][Full Text] [Related]
2. Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
Moresco L; Sjögren A; Marques KA; Soll R; Bruschettini M
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015462. PubMed ID: 37791592
[TBL] [Abstract][Full Text] [Related]
3. Methylxanthine for the prevention and treatment of apnea in preterm infants.
Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Doxapram for the prevention and treatment of apnea in preterm infants.
Evans S; Avdic E; Pessano S; Fiander M; Soll R; Bruschettini M
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD014145. PubMed ID: 37877431
[TBL] [Abstract][Full Text] [Related]
6. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome.
Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216
[TBL] [Abstract][Full Text] [Related]
7. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Walker E; Osborn DA
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
[TBL] [Abstract][Full Text] [Related]
8. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631
[TBL] [Abstract][Full Text] [Related]
9. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; van de Loo M; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
[TBL] [Abstract][Full Text] [Related]
10. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
[TBL] [Abstract][Full Text] [Related]
12. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
[TBL] [Abstract][Full Text] [Related]
13. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; De Jaegere AP; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
[TBL] [Abstract][Full Text] [Related]
14. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Shepherd ES; Goldsmith S; Doyle LW; Middleton P; Marret S; Rouse DJ; Pryde P; Wolf HT; Crowther CA
Cochrane Database Syst Rev; 2024 May; 5(5):CD004661. PubMed ID: 38726883
[TBL] [Abstract][Full Text] [Related]
15. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
16. Nasal high flow therapy for primary respiratory support in preterm infants.
Hodgson KA; Wilkinson D; De Paoli AG; Manley BJ
Cochrane Database Syst Rev; 2023 May; 5(5):CD006405. PubMed ID: 37144837
[TBL] [Abstract][Full Text] [Related]
17. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.
Walters A; McKinlay C; Middleton P; Harding JE; Crowther CA
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD003935. PubMed ID: 35377461
[TBL] [Abstract][Full Text] [Related]
18. Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates.
Kinoshita M; Stempel KS; Borges do Nascimento IJ; Bruschettini M
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD014876. PubMed ID: 36870076
[TBL] [Abstract][Full Text] [Related]
19. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
Mitra S; Scrivens A; von Kursell AM; Disher T
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
[TBL] [Abstract][Full Text] [Related]
20. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
